Chemed (NYSE:CHE) Director Patrick Grace Sells 190 Shares

Chemed Corporation (NYSE:CHE) Director Patrick Grace sold 190 shares of Chemed stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Chemed Trading Up 1.7%

Shares of CHE stock traded up $9.12 on Monday, hitting $541.38. 109,731 shares of the stock traded hands, compared to its average volume of 222,150. The stock has a market capitalization of $7.19 billion, a PE ratio of 27.16, a PEG ratio of 2.02 and a beta of 0.52. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $551.68. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The firm’s 50-day moving average price is $467.11 and its two-hundred day moving average price is $436.50.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The company had revenue of $673.25 million for the quarter, compared to the consensus estimate of $665.04 million. During the same quarter in the previous year, the business earned $4.27 earnings per share. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, analysts anticipate that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.4%. The ex-dividend date was Thursday, May 28th. Chemed’s payout ratio is 12.05%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Bank of America reissued a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday. Royal Bank Of Canada lifted their price target on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Chemed currently has an average rating of “Hold” and an average price target of $530.75.

Institutional Investors Weigh In On Chemed

Several large investors have recently modified their holdings of the stock. Commonwealth Equity Services LLC lifted its position in shares of Chemed by 3.1% in the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after purchasing an additional 22 shares in the last quarter. Cim LLC grew its position in Chemed by 1.1% in the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after purchasing an additional 24 shares during the last quarter. Eukles Asset Management increased its position in shares of Chemed by 0.4% during the fourth quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock valued at $2,591,000 after purchasing an additional 25 shares during the period. MassMutual Private Wealth & Trust FSB lifted its stake in Chemed by 65.3% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock worth $38,000 after purchasing an additional 32 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Chemed by 9.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock valued at $153,000 after purchasing an additional 35 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.